BridgeMD
New treatment option for Breast Carcinoma
Official title A Post-treatment Supportive Service Program for the Transition Into Survivorship for Black Women Breast Cancer Survivors in Western New York
ClinicalTrials.gov ID: NCT06833255
What this study is testing
- What it's testing
- This clinical trial studies whether a post-treatment supportive service program can be used to help breast cancer survivors in Western New York (WNY) transition into post-treatment life (survivorship). The post-treatment supportive service program is delivered to breast cancer survivors of WNY.
- Time commitment: about 12 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Ability to speak and read English
- At least 18 years of age or older
- Live in the Western New York area
- Has been diagnosed with breast cancer (any stage)
- Has completed primary breast cancer treatments (i.e., systemic, radiation, and/or surgical interventions other than breast reconstruction surgeries)
You likely can't join if
- Note: Although any breast cancer survivor may participate, priority will be given to those who have most recently transitioned into their...
- Currently receiving neoadjuvant and/or adjuvant systemic and/or radiations therapies
- Unwilling or unable to complete the assessment in English
- Are pregnant or nursing
- Are unwilling or unable to follow protocol requirements
- Note: Individuals who have completed primary breast cancer treatments who are being managed with ongoing hormonal therapies and/or are awaiting...
See the full eligibility criteria
- Ability to speak and read English
- At least 18 years of age or older
- Live in the Western New York area
- Has been diagnosed with breast cancer (any stage)
- Has completed primary breast cancer treatments (i.e., systemic, radiation, and/or surgical interventions other than breast reconstruction surgeries)
- Mentors are at least one-year post-treatment completion
- Mentees are less than one-year post-treatment completion
- Note: Individuals who have completed primary breast cancer treatments who are being managed with ongoing hormonal therapies and/or are awaiting breast reconstruction surgery may participate in this study (i.e., these...
- Note: Although any breast cancer survivor may participate, priority will be given to those who have most recently transitioned into their post-treatment life (or those who report that support was either not offered or...
- Currently receiving neoadjuvant and/or adjuvant systemic and/or radiations therapies
- Unwilling or unable to complete the assessment in English
- Are pregnant or nursing
- Are unwilling or unable to follow protocol requirements
- Note: Individuals who have completed primary breast cancer treatments who are being managed with ongoing hormonal therapies and/or are awaiting breast reconstruction surgery may participate in this study (i.e., these...
The study team makes the final eligibility decision.
Where it's taking place
- Buffalo, New York, United States
Compensation & support
Some study costs may be covered.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Buffalo, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.